CompletedNot Applicable

Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion

South Korea28,322 participantsStarted 2018-01-03

Plain-language summary

Retrospective cohort study of Korean National Healthcare Insurance Database. To investigate clinical outcomes of bare metal stents versus drug eluting stents in patients who underwent periprocedural red blood cell transfusion.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with percutaneous coronary intervention from 2006 to 2015 * Patients with the implantation of BMS or DES * Patients with the receipt of periprocedural red blood cell transfusion Exclusion Criteria: * Patients without any of stent implantation

What they're measuring

Incidence density of MACE (Major adverse clinical events)

Timeframe: 3 years

Incidence density of MACE (Major adverse clinical events)

Timeframe: 1 year

Trial details

NCT IDNCT03788148

SponsorSamsung Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-11-30

View on ClinicalTrials.gov More Erythrocyte Transfusion trials